Hybrid core–shell scaffolds for bone tissue engineering

Abstract

The tissue engineering applications of coaxial electrospinning are growing due to the potential increased functionality of the fibres compared to basic electrospinning. Previous studies of core and shell scaffolds have placed the active elements in the core, however, the surface response to a biomaterial affects the subsequent behaviour, thus here hydroxyapatite (HA) was added to the shell. Coaxial electrospun polycaprolactone (PCL)-polylactic acid (PLA)/HA (core–shell) scaffolds were produced in 2D sheets using a plate collector, or 3D tubes for bone tissue engineering using a rotating needle collector. The scaffolds include high hydroxyapatite content while retaining their structural and mechanical integrity. The effect of the collector type on fibre diameter, fibre alignment and mechanical properties have been evaluated, and the impact of HA incorporation on bioactivity, BMP-2 release, cell behaviour and mechanical properties for up to 12 weeks degradation were assessed. Fibre uniformity in coaxial electrospinning depends on the relative flow rate of the core and shell solutions. Using a rotating needle collector increased fibre alignment compared to a stationary collector, without affecting fibre diameter significantly, while HA content increased fibre non-uniformity. Coaxial PCL-PLA/HA fibres exhibited significantly higher bioactivity compared to PCL-PLA scaffolds due to the surface exposure of the HA particles. Apatite formation increased with increasing SBF immersion time. Coaxial tubular scaffolds with and without HA incorporation showed gradual reductions in their mechanical properties over 12 weeks in PBS or SBF but still retained their structural integrity. Coaxial scaffolds with and without HA exhibited gradual and sustained BMP-2 release and supported MSCs proliferation and differentiation with no significant difference between the two scaffolds types. These materials therefore show potential applications as bone tissue engineering scaffolds.

Recent Advances in Bioplastics: Application and Biodegradation

“…This led to a distinctive osteoclastic differentiation as well as to a reduced immunogenic effect by magnesium hydroxide, and a better mechanical and physiological response induced by the PLGA/calcium phosphate composite. The processing of the starting polymer was shown to be critical in inducing specific outcomes for the plated cells, as shown by Kareem and colleagues [153]. They have found that a core-shell electrospinning to fabricate a PCL/PLLA scaffold with hydroxyapatite particles allowed an osteoconductive environment and also induced differentiation of human mesenchymal stem cells (hMSCs).…”

Bone Morphogenetic Protein 2 (BMP-2) Aggregates Can be Solubilized by Albumin—Investigation of BMP-2 Aggregation by Light Scattering and Electrophoresis

“…There are about a hundred published release studies with BMP-2 every year. In many cases, the release studies are carried out in PBS without any solubility increasing additives [9][10][11][12][13][14][15][16]. However, there are only a few publications that refer to the low solubility of the protein and the associated potential influence, both on the release itself (violation of sink conditions), and on the quantification of the partially aggregated protein [17].…”

Poly(lactic Acid): A Versatile Biobased Polymer for the Future with Multifunctional Properties—From Monomer Synthesis, Polymerization Techniques and Molecular Weight Increase to PLA Applications

“…The 3D printing technique is based on a controlled dispensing system integrated with pumping technology and a CAD/CAM system allows the precise and reproducible fabrication of 3D structures with well-defined predetermined geometries 3D printed PLA-based scaffolds. PLA emergence in 3D printing technology led to development of scaffolds in desired shapes and forms, in low cost, with corresponding mechanical and biological properties and controlled micro/nano structures [ 172 , 173 ].…”

“…The results in situ showed a decrease in postsurgical inflammation, to avoid infection and reduce the incidence of secondary cataract while having a programmed release of quantity and release profiles to cut down the need of eye drops in order to prevent inflammation or infection and to decrease the posterior capsular opacification following cataract surgery [ 221 ]. PLA, nHA and Eudragit produced double-layer microspheres were loaded with human insulin-like growth factor 1, and the results provide a promising therapeutic suggestion in order to delay osteoporosis and articular degeneration [ 172 , 222 ]. Rhodamine B as a model drug substance was loaded into PLA microchamber arrays that were prepared by dip-coating a PDMS stamp into PLA.…”